Trial
NCT00854581
Zidovudine, Interferon Alfa-2b, PEG-Interferon Alfa-2b in Patients With HTLV-I Associated Adult T-Cell Leukemia/Lymphoma
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Miami
Collaborators
National Cancer Institute (NCI)
Condition
Lymphoma
Intervention
PEG-interferon alfa-2b
Why stopped
Investigator Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-04-17